BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2016
View Archived Issues
Bayer initiates phase I trial of BAY-1436032 in patients with IDH1-R132X mutant solid tumors
Read More
Janssen initiates first-in-human study of JNJ-61186372 in advanced NSCLC
Read More
Hikma acquires a portfolio of six injectable products in Europe
Read More
Xencor and Novartis establish bispecific collaboration
Read More
FDA places clinical hold on Regulus' IND for RG-101 for chronic HCV infection
Read More
University of Michigan conducts first-in-human studies for new PET tracers
Read More
Puma submits MAA to the EMA for neratinib
Read More
The Jackson Laboratory patents DNA repair inhibitors
Read More
EMA recommends approval of Keytruda for advanced NSCLC
Read More
Shanghai Sun-Sail Pharmaceutical Science & Technology describes antituberculosis compounds
Read More
GW Pharmaceuticals announces positive phase III pivotal trial results for Epidiolex
Read More
LabCorp announces launch of Roche cobas EGFR Mutation Test v2
Read More
Agilis Biotherapeutics receives CRADA
Read More
RhoU GTPase shows promise as a therapeutic target for MM
Read More
Bristol-Myers Squibb receives new breakthrough therapy designation for Opdivo
Read More
First-in-human results for ONO-4232
Read More
FDA grants priority review to Ocrevus BLA for relapsing and primary progressive forms of MS
Read More
Carbavance meets primary endpoints in phase III TANGO 1 study in patients with cUTI
Read More
IL-22 linked to aberrant bone formation in spondyloarthropathies
Read More
European Commission approves Zavicefta for serious bacterial infections
Read More
PolypDx urine-based diagnostic test for adenomatous polyps launched in U.S.
Read More
Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections
Read More
FDA accepts Advanced Accelerator Applications' NDA for Lutathera
Read More
